RecruitingNCT05790785
Vascular Complications in Children From T1D Diagnosis
Understanding Vascular Complications in Children From Type 1 Diabetes Diagnosis
Sponsor
University of British Columbia
Enrollment
150 participants
Start Date
Mar 25, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Cardiovascular disease is a complication of type 1 diabetes (T1D), a life-long disease, usually diagnosed in childhood. The goal of this project is to determine the timing and factors leading to vascular damage in children from T1D diagnosis.
Eligibility
Min Age: 8 YearsMax Age: 18 Years
Inclusion Criteria3
- Between the ages of 8-18 years
- Within 14 weeks of type 1 diabetes diagnosis
- Ability and willingness to undergo non-invasive arterial stiffness assessment for 1hr and willingness to wear the 24-h automated blood pressure monitoring (ABPM) device.
Exclusion Criteria6
- Children will be ineligible to participate in the study if they meet any of the following:
- Other cardiometabolic or endocrine diseases diagnosis (type 2 diabetes; familial disorders of cholesterol metabolism; lupus)
- Other genetic syndromes (Down Syndrome; Prader-Willi)
- Eating disorder diagnosis
- Transgender children taking hormone blockers or exogenous sex steroids
- Currently treated with medications known to affect metabolism (e.g. glucocorticoids, antipsychotics).
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05790785
Related Trials
French Prospective Multicentric Study in Real World
NCT0703994224 locations
Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes
NCT059087081 location
Immune Function and the Progression to T1D
NCT058994393 locations
Enhancing Brain And Mental Health Through Breathing Practice
NCT073697522 locations
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
NCT0643515617 locations